No Data
Analyst Expectations For Natera's Future
Natera Is Maintained at Overweight by Piper Sandler
Express News | Natera Inc : Piper Sandler Raises Target Price to $200 From $150
What kind of company is Natera, the largest hold positions of Drew Miller?
Currently, there is a lack of precision in adjuvant therapy plans after tumor (MRD) surgery, while MRD testing can detect molecular abnormalities originating from the tumor, enabling early detection of cancer recurrence and guiding precise postoperative treatment. Huayuan Securities believes that natera's MRD testing business has significant competitive advantages, and its launched Signatera product is expected to become the core driving force behind the company's rapid performance improvement.
Natera(NTRA.US) Director Sells US$5.44 Million in Common Stock
Natera(NTRA.US) Director Sells US$5.62 Million in Common Stock
No Data
No Data
not-a-cow : How come your data is different from fintel?
In One Chart OP not-a-cow : Hi, which part is different? Let me check it
104088143 : like
Adrianlim90 : 1
Adrianlim90 : 1
View more comments...